Considering these data, we next investigated whether the NXP800-mediated increase in eIF2α phosphorylation and ATF4, ATF6, and IRE1 protein expression was beneficial or detrimental to these prostate cancer models studied. This evidence concerns the gene EIF2A and prostate carcinoma.